Stocks extended gains in March as countries pushed ahead with their COVID-19 vaccine rollouts, the US passed a new stimulus package and major central banks indicated they are likely to keep interest rates low even as the economy rebounds.
Stocks climbed in February on continued hopes for a post-lockdown economic recovery. Benchmark indices pared more than half of their advance at the end of the month following a spike in bond yields and inflation expectations.
The STOXX® Global 1800 Index rose 4.3% in dollars in December, cementing a second straight year of double-digit percentage gains, as investors raised expectations that policy support and vaccines will help economies overcome the COVID-19-induced slump.
The STOXX® Global 1800 Index surged 12.9% in dollars in November, its largest monthly increase since data begins in 2004, as three drugs manufacturers announced their experimental vaccines are widely effective in preventing the COVID-19 virus.